Status:
RECRUITING
Detection and Prediction of Clinically Significant Pneumothorax After Image-guided Transthoracic Lung Biopsy
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Lung Biopsy
Eligibility:
All Genders
18+ years
Brief Summary
Objective: The goal of this study is to evaluate the sensitivity and specificity of the presence of pneumothorax on a 4-hour CXR after image-guided transthoracic lung biopsy (TTLB) for diagnosing subs...
Detailed Description
Image-guided transthoracic lung biopsy (TTLB), by computed tomography (CT) or ultrasound guidance, is an important diagnostic modality for various pulmonary diseases. One of the most common and clinic...
Eligibility Criteria
Inclusion
- Patients whose image-guided TTLB, including ultrasound or CT-guided, is arranged for diagnostic purposes
- Patients who are able to sign written informed consent to participate in the study
Exclusion
- Patients with resolution of lung lesion prior to the scheduled image-guided TTLB
- Patients have active exacerbation of underlying diseases causing unstable respiratory conditions (e.g. exacerbation of COPD, pneumonia) which would lower the threshold for invasive interventions for iatrogenic pneumothorax
- Patients with psychiatric disease or cognitive impairment that may limit their ability to understand or give consent to the study
- Patients who decline to join the study
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06563167
Start Date
September 1 2024
End Date
December 31 2026
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese University of Hong Kong
Hong Kong, Hong Kong